Willingness to accept a second COVID-19 vaccination booster dose among healthcare workers in ItalyArticle Published on 2022-12-092023-07-11 Journal: Frontiers in Public Health [Category] COVID19(2023년), [키워드] COVID-19 HCWs Italy second booster dose vaccination willingness. [DOI] 10.3389/fpubh.2022.1051035 PMC 바로가기
COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in Malaysia말레이시아에서 BNT162b2 백신을 접종한 의료 종사자의 COVID-19 획기적인 감염 및 체액성 면역 반응Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] 95% CI affected age Anti-S1 Anti-spike antibody Antibody Response antibody titres association Asymptomatic Asymptomatic individuals blood sample Blood samples BNT162b2 booster vaccination breakthrough Breakthrough infection breakthrough infections collected COVID-19 COVID-19 infection delta variant detectable domain geometric mean geometric mean titre GMT HCWs healthcare healthcare worker Healthcare workers humoral humoral immune response Humoral immunity IgG IgG assay individual individuals Infection investigated Malaysia not different notable outcome Participants prospective cohort study Protein response significantly significantly higher Support symptomatic the antibody response vaccination Vaccine vaccine doses vaccine. waned was measured [DOI] 10.1080/22221751.2022.2065936 PMC 바로가기 [Article Type] Article
Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infectionsArticle Published on 2022-12-012022-11-15 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] addition Anti-RBD IgG antibody Breakthrough infection Cell cellular immunity cellular response circulating Delta Diagnosis Dynamics exhibited faster greater HCW HCWs healthcare worker humoral IFN-γ Immunity Infection infectiousness investigated isolates median neutralization capacity neutralizing antibody titre normalized omicron pandemic positive pre-existing immunity proportion reported RT-qPCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 isolates SARS-CoV-2 peptides SARS-CoV-2 variants symptom onset Vaccine vaccine-immunity variant viral clearance viral culture Viral load viral loads viral shedding Viral shedding. [DOI] 10.1080/22221751.2022.2122578 PMC 바로가기
The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis후속 SARS-CoV-2 감염에 대한 자연 획득 항체의 보호: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-12-012022-09-12 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI Acquired Against analyses analysis antibody asymptomatic infection conducted COVID-19 COVID-19 case COVID-19 infection COVID-19 vaccination Efficacy eligible General population HCWs Health care worker incidence rate individual Infection Meta-analysis Naturally naturally acquired antibody naturally acquired immunity Newcastle-Ottawa Scale NOS Older outcome Population programming protection provided reduce Registration Reinfection reinfection. review risk SARS-CoV-2 SARS-COV-2 infection searched seropositive significant difference significantly specific antibody subsequent symptomatic was used [DOI] 10.1080/22221751.2022.2046446 PMC 바로가기 [Article Type] Meta-Analysis
Demographic, behavioural and occupational risk factors associated with SARS-CoV-2 infection in UK healthcare workers: a retrospective observational studyArticle Published on 2022-11-072022-11-15 Journal: BMJ Open [Category] SARS, 변종, 진단, [키워드] 95% CI Analysis assessment behavioural COVID-19 demographic Diseases effective enhanced enrolled Epidemiology Factor General population HCW HCWs Health healthcare Healthcare system healthcare worker higher risk highest hospital identify include Infection infection control investigated Logistic regression measure multivariate logistic regression Observational cohort study occupational Pandemics Personal protective equipment Physiotherapist positive PPE Public public health. questionnaire Regression model Reporting Resilience retrospective risk risk factor risk reduction SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 variant Selection Shrinkage social distancing social distancing measures stability sustained Vaccine variable was used Workplace [DOI] 10.1136/bmjopen-2022-063159 PMC 바로가기
A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospitalArticle Published on 2022-11-012022-11-15 Journal: The Journal of Infection [Category] SARS, 진단, [키워드] 95% CI accounted age analysed Asian assistant Bame black conducted COVID-19 Factor Factors Fever group HCW HCWs healthcare healthcare worker Healthcare workers heterogeneous higher risk hospital immunoassay Increased increased risk independent multivariable model multivariate logistic regression positive Prospective Study reported risk risk factor risk factor analysis SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection sense of taste sero-epidemiology. Seroprevalence Sex significantly significantly higher staff Symptom Symptoms tested [DOI] 10.1016/j.jinf.2022.08.030 PMC 바로가기
Antibody responses and SARS-CoV-2 infection after BNT162b2 mRNA booster vaccination among healthcare workers in JapanArticle Published on 2022-11-012022-11-15 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 진단, [키워드] 95% confidence interval 95%CI adjusted odds ratio age analyzed anti-spike antibody Antibody Response BNT162b2 BNT162b2 mRNA booster vaccination Booster vaccine Cohort Coverage COVID-19 decrease dose Effectiveness eight Factor group groups HCW HCWs Health care worker healthcare worker Increased infection control interquartile range introduced IQR Japan median mRNA vaccine mRNA vaccine. multivariate logistic regression no significant difference not significant positive risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections subject university vaccination Vaccine waning immunity [DOI] 10.1016/j.jiac.2022.07.010 PMC 바로가기
COVID-19 vaccine breakthrough infection among fully vaccinated healthcare workers in Duhok governorate, Iraqi Kurdistan: A retrospective cohort studyArticle Published on 2022-11-012022-11-16 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, [키워드] association Break through infections Breakthrough infection COVID-19 COVID-19 vaccine dentist determine Duhok effective Effectiveness enrolled females fill out fully vaccination HCW HCWs healthcare healthcare worker Healthcare workers highest incidence Infection infections Iraqi Kurdistan majority male Mild moderate MOST multicenter omicron outcomes paramedics participant Pfizer polymerase chain positive postvaccination prevaccination questionnaire random respiratory retrospective cohort study risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant severity significantly the disease the vaccine Vaccine vaccine effectiveness. variant was performed [DOI] 10.1002/jmv.27985 PMC 바로가기
Effectiveness of COVID-19 vaccination in healthcare workers in Shiga Prefecture, JapanArticle Published on 2022-10-212022-11-15 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 진단, [키워드] Abbott analyzed antibody Cell cells Cellular immune response cellular immunity conducted coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccinations Delta effective evaluated HCW HCWs health condition healthcare worker Hospitalization humoral induce Japan Poor questionnaire repeated required Roche SARS-CoV-2 SARS-COV-2 infection serological seropositive Standard deviation vaccination Vaccine Wuhan-1 [DOI] 10.1038/s41598-022-22682-3 PMC 바로가기
Presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies Among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 VaccineArticle Published on 2022-10-032022-11-15 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] adverse event All participant antibody Antibody testing baseline ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 vaccine conducted coronavirus 2 cPass™ delta variant detectable detected antibody doses Dosing dosing interval dosing schedule Effectiveness Follow-up Genscript HCW HCWs healthcare worker IgG antibody immunization interval laboratory-confirmed neutralizing antibody no significant difference offer participant PCR testing performed Presence Prevalence prospective cohort study reported respiratory SARS-CoV-2 second dose Seroprevalence suggested the SARS-CoV-2 vaccination vaccination. Vaccine vaccine-induced antibodies worker [DOI] 10.1093/cid/ciac493 PMC 바로가기